NCT01060514 Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer Status TERMINATED Phase PHASE1
NCT01056757 Treatment With Ribavirin for Patients With Metastatic Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01053104 Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring Status COMPLETED Phase N/A
NCT01045421 Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT01044485 Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01036113 A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT01033032 Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01029925 Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL) Status TERMINATED Phase PHASE2
NCT01027208 A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline Status COMPLETED Phase PHASE2
NCT01025349 Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01019577 Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant Status COMPLETED Phase PHASE2
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Status COMPLETED Phase PHASE2
NCT01007942 Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT01004172 Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases Status COMPLETED Phase PHASE2
NCT00988936 Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug Status COMPLETED Phase PHASE2
NCT00983424 Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00976365 Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00958971 Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00952692 Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2